BREAKINGUSDJPY and XAUUSD react as US carrier arrives in Middle East amid Iran tensions

China threatens countermeasures as US widens investment curbs to biotech and AI

China's commerce ministry said it reserves the right to retaliate after the US Treasury proposed widening its limits on American investment in Chinese tech to include biotechnology.

BOND MARKETSYIELDSFXROLL

China has warned it may hit back after Washington moved to tighten rules on US money flowing into Chinese technology companies.

Last Thursday the US Treasury proposed expanding its Outbound Investment Security Program, a set of rules that limits what Americans can invest in sensitive industries in countries the US calls foreign adversaries: China, Russia and North Korea. The plan tightens existing limits on artificial intelligence, quantum technology, hypersonics, high-performance computing and supercomputing, and adds biotechnology to the list for the first time.

Treasury Secretary Scott Bessent, who pushed for the biotech addition, said the changes would stop rivals from using American capital to build critical technologies. The proposal must first go through a public comment period, so the final rule could still change. No start date has been given.

On Saturday, China's commerce ministry rejected the plan. A spokesperson called it discriminatory and a "classic example of stretching the concept of national security too far". The ministry said it would follow developments closely, warned of damage to economic ties and said China "reserves the right" to take countermeasures, without saying what they would be.

The dispute adds to other friction this week. The US State Department sanctioned five Chinese companies linked to a former Google engineer convicted earlier this year of stealing AI trade secrets, a move Beijing also condemned.

What it means for traders

No market moves were reported over the weekend, but the row adds headline risk for Chinese tech and biotech shares, including US-listed Chinese stocks and the Hang Seng Tech index. Biotech is the newly targeted sector. If the language between Washington and Beijing hardens, the offshore yuan (CNH) and wider risk appetite could come under pressure. The long comment period means the issue may stay open for some time.

Risk warning: Trading foreign exchange and CFDs on margin carries a high level of risk and may not be suitable for all investors. Leverage can work against you. Content on FXROLL is for information and education only and is not investment advice. Prices and data may be delayed or contain errors.

Keep reading

More news →